Table 1.
Dysregulation in COVID-19 | Effect of IFN β administration | |
---|---|---|
APC |
↓ pDC impairs antigen presentation and reduces type I IFN production. ↓ mTOR levels in pDC [76] |
↑ DC differentiation from CD14+ monocytes and CD34+ progenitors [77] ↓ naive T cell activation in draining lymph nodes by inhibiting DC migration [72]. ↓ Antigen presentation by downregulating IFN-γ induced MHC II molecule expression among non-professional APC [78]. |
T cells |
↓ CD4+ T cell and CD8+ T cell leading to pathogen persistence. ↑ Tex exhibits dysregulated function. ↑ CD4+ CCR6+ (Th17) secretes IL-17 which recruits neutrophils and induces pro-inflammatory cytokines such as IL-1β and TNF α. ↑ CD4+ CXCR3+ (Th1) secretes GM-CSF and IFN-γ. IFN-γ increases MHC I and II antigen presentation, chemokine secretion, macrophage activation, and phagocytosis, on the other hand, GM-CSF activates CD14+ CD16+ monocytes that secretes high levels of IL-6 [49]. |
↑ CD4+ CD25+ Foxp3+ (T reg) population secretes IL-10 and TGF β which inhibits T cell activation and Th1/Th2 differentiation. ↑ Bcl2 expression among the T reg population. ↑ CD4+ CCR4+ (Th2) secretes IL-4 which actively inhibits activated macrophage and pro-inflammatory cytokines such as IL-1 and TNF. ↓ IL-17 through T reg population [79] |
B cell | ↓ CD3− CD19+ B cell impairs pathogen clearance [80]. |
↑ CD69, CD86, and MHC II on the B cell surface which enhances B cell function. ↑ Bcl2 expression leading to B cell survival [81] |
Cytokines |
↑ IL-2, IL-6, IL-1β, IL-1Ra, TNF α, and IFN-γ leading to cytokine storm syndrome. ↓Type I IFN and type III IFN impairs innate immune response [82] |
↑ IL-10 and IL-4 actively inhibit immune cell activation and recruitment. ↓ IL-1β maturation by inhibiting inflammasome activation [83] |
Others |
↑ Neutrophils secrete IL-1β and IL-1Ra. ↓ Monocytes, eosinophil, and basophil [82] |
↑ Neutrophils apoptosis and efferocytosis [74] |
pDC, plasmacytoid dendritic cell; Th, T helper cells; T reg, T regulatory cells; T ex, exhausted state T cell; IL, interleukins; MHC, major histocompatibility complex; GM-CSF, granulocyte-macrophage colony-stimulating factor; TNF, tumor necrosis factor; IFN, interferon; mammalian target of rapamycin (mTOR);